Skip to main content

Table 2 S. aureus, Coagulase-negative staphylococci, E. faecalis, and E. faecium isolated from ICU patients during 2000–2002

From: Emerging resistance among bacterial pathogens in the intensive care unit – a European and North American Surveillance study (2000–2002)

  

United States

Canada

Italy

Germany

Francea

Organism

Agent

Total n

%S

%R

Total n

%S

%R

Total n

%S

%R

Total n

%S

%R

Total n

%S

%R

Staphylococcus aureus

Ampicillin

19,703

6.7

93.3

3,792

12.6

87.4

1,665

5.6

94.4

2,867

16.2

83.8

15

6.7

93.3

 

Cefepime

1,260

52.9

46.9

NTb

NT

NT

304

15.8

84.2

483

80.5

17.0

<10

NAc>

NA

 

Cefotaxime

6,898

50.2

49.7

220

55.5

44.5

671

36.4

63.6

729

92.0

8.0

490

63.9

36.1

 

Ceftriaxone

5,914

45.6

54.3

153

69.3

30.7

1,048

28.1

71.8

220

88.6

11.4

23

73.9

26.1

 

Ciprofloxacin

24,350

47.4

51.0

5,958

74.5

24.1

4,600

39.7

58.6

5,243

73.4

26.1

316

57.0

40.5

 

Gentamicin

35,034

85.6

13.7

6,641

89.4

10.3

5,531

40.9

58.0

5,735

90.0

9.7

10,100

90.4

9.4

 

Oxacillin

44,939

47.7

52.3

10,105

80.3

19.7

6,147

40.6

59.4

6,475

79.0

21.0

10,512

59.4

40.6

 

Teicoplanin

NT

NT

NT

NT

NT

NT

5,868

100

0

4,632

99.8

0.2

8,232

100

0

 

Vancomycin

43,245

100

0

7,882

100

0

5,937

100

0

5,276

100

0

9,453

100

0

Staphylococcus aureus

                

OSSA

Ampicillin

9,047

14.5

85.5

3,055

15.7

84.3

741

12.6

87.4

2,414

19.3

80.7

10

0

100

 

Cefepime

672

99.1

0.4

NT

NT

NT

49

98.0

2.0

387

99.5

0.3

NT

NT

NT

 

Cefotaxime

3,451

99.7

0.2

122

100

0

244

100

0

653

100

0

312

100

0

 

Ceftriaxone

2,707

99.5

0.2

106

100

0

295

99.0

0.3

194

100

0

16

100

0

 

Ciprofloxacin

11,827

91.2

6.5

4,692

93.5

4.8

1,902

91.4

4.9

4,171

91.4

8.0

188

90.4

6.4

 

Gentamicin

16,951

98.3

1.4

5,384

98.1

1.8

2,223

95.1

4.5

4,527

98.4

1.5

5,958

99.4

0.5

 

Oxacillin

21,416

100

0

8,110

100

0

2,495

100

0

5,115

100

0

6,244

100

0

 

Teicoplanin

NT

NT

NT

NT

NT

NT

2,402

100

0

3,593

99.9

0.1

5,018

100

0

 

Vancomycin

20,110

100

0

6,046

100

0

2,430

100

0

4,002

100

0

5,580

100

0

Staphylococcus aureus

                

ORSA

Ampicillin

10,656

0

100

737

0

100

924

0

100

453

0

100

<10

NA

NA

 

Cefepime

588

0

100

NT

NT

NT

255

0

100

96

4.2

84.4

<10

NA

NA

 

Cefotaxime

3,447

0.6

99.3

98

0

100

427

0

100

76

23.7

76.3

178

0.6

99.4

 

Ceftriaxone

3,207

0

100

47

0

100

753

0.3

99.7

26

3.8

96.2

<10

NA

NA

 

Ciprofloxacin

12,523

6.1

93.1

1,266

3.9

95.5

2,698

3.3

96.4

1,072

3.3

96.6

128

7.8

90.6

 

Gentamicin

18,083

73.7

25.2

1,257

52.0

46.8

3,308

4.5

94.0

1,208

58.7

40.5

4,142

77.5

22.2

 

Oxacillin

23,523

0

100

1,995

0.2

99.8

3,652

0

100

1,360

0

100

4,268

0

100

 

Teicoplanin

NT

NT

NT

NT

NT

NT

3,466

100

0

1,039

99.7

0.3

3,214

100

0

 

Vancomycin

23,135

100

0

1,836

100

0

3,507

100

0

1,274

100

0

3,873

100

0

Staphylcoccus species, coagulase-negative

                
 

Ampicillin

16,288

5.7

94.3

3,533

6.3

93.7

2,142

10.6

89.4

4,075

8.1

91.9

<10

NA

NA

 

Cefepime

991

11.8

88.1

<10

NA

NA

116

0

100

625

11.0

73.1

<10

NA

NA

 

Cefotaxime

5,538

17.7

82.3

240

17.9

82.1

335

16.7

83.3

625

37.4

62.4

174

28.7

69.0

 

Ceftriaxone

3,471

14.8

84.8

116

22.4

77.6

512

11.7

88.3

412

25.0

74.8

<10

NA

NA

 

Ciprofloxacin

18,829

40.2

58.3

5,366

44.4

54.7

5,102

42.7

54.0

6,197

29.5

67.6

198

44.4

53.0

 

Gentamicin

27,248

51.5

38.1

5,571

40.6

47.3

5,241

33.8

60.7

6,848

41.5

51.7

9,422

46.8

51.5

 

Oxacillin

35,135

15.8

84.2

9,172

20.6

79.4

5,961

15.2

84.8

7,442

18.6

81.4

9,884

30.1

69.9

 

Teicoplanin

NT

NT

NT

NT

NT

NT

5,797

93.7

2.4

5,096

95.6

0.7

7,670

84.6

3.1

 

Vancomycin

34,424

100

0

8,239

100

0

5,937

100

0

6,953

100

0

8,300

100

0

Staphylcoccus species, coagulase-negative

                

Oxacillin susceptible

Ampicillin

2,582

35.7

64.3

638

34.6

65.4

437

51.7

48.3

824

39.6

60.4

<10

NA

NA

 

Cefepime

117

100

0

NT

NT

NT

NT

NT

NT

<10

NA

NA

NT

NT

NT

 

Cefotaxime

978

99.5

0.2

42

100

0

56

100

0

128

100

0

54

92.6

0

 

Ceftriaxone

523

98.3

0.4

26

100

0

59

100

0

103

100

0

<10

NA

NA

 

Ciprofloxacin

2,844

82.4

16.6

988

91.8

7.6

779

87.7

10.1

1,103

89.5

9.2

78

83.3

14.1

 

Gentamicin

4,424

93.5

4.2

1,068

91.9

5.3

698

94.3

5.3

1,263

96.5

2.7

2,822

93.9

5.4

 

Oxacillin

5,565

100

0

1,886

99.9

0.1

904

100

0

1,383

100

0

2,980

100

0

 

Teicoplanin

NT

NT

NT

NT

NT

NT

890

99.1

0.3

691

98.4

0.3

2,454

95.8

0.2

 

Vancomycin

5,240

100

0

1,587

100

0

897

100

0

981

100

0

2,467

100

0

Staphylcoccus species, coagulase-negative

                

Oxacillin resistant

Ampicillin

13,706

0.1

99.9

2,895

0

100

1,705

0

100

3,251

0.2

99.8

<10

NA

NA

 

Cefepime

874

0

99.9

<10

NA

NA

116

0

100

624

10.9

73.2

<10

NA

NA

 

Cefotaxime

4,560

0.1

99.9

198

0.5

99.5

279

0

100

497

21.3

78.5

120

0

100

 

Ceftriaxone

2,948

0

99.8

90

0

100

453

0.2

99.8

309

0.0

99.7

<10

NA

NA

 

Ciprofloxacin

15,985

32.7

65.8

4,378

33.7

65.3

4,323

34.7

61.9

5,094

16.5

80.2

120

19.2

78.3

 

Gentamicin

22,824

43.3

44.7

4,503

28.5

57.3

4,543

24.5

69.2

5,585

29.1

62.8

6,600

26.6

71.3

 

Oxacillin

29,570

0

100

7,286

0

100

5,057

0

100

6,059

0

100

6,904

0

100

 

Teicoplanin

NT

NT

NT

NT

NT

NT

4,907

92.7

2.8

4,405

95.1

0.8

5,216

79.3

4.5

 

Vancomycin

29,184

100

0

6,652

100

0

5,040

100

0

5,972

100

0

5,833

100

0

Enterococcus faecalis

                
 

Ampicillin

7,865

98.8

1.2

1,000

99.4

0.6

1,289

95.3

4.7

1,902

99.6

0.4

1,183

99.5

0.2

 

Ciprofloxacin

3,311

56.9

38.7

625

45.3

50.4

1,159

64.0

31.1

2,012

39.7

39.5

559

78.5

17.0

 

Gentamicin (HL Testing)

5,503

65.1

34.8

706

63.0

36.8

1,156

62.9

37.1

965

64.8

35.2

1,563

63.6

13.4

 

Teicoplanin

NT

NT

NT

<10

NA

NA

1,248

97.1

2.4

1,294

99.7

0.2

1,747

99.9

0.1

 

Vancomycin

7,656

95.1

4.5

1,005

98.3

0.9

1,303

96.7

2.8

1,636

99.4

0.3

1,811

99.7

0.2

Enterococcus faecium

                
 

Ampicillin

3,896

9.7

90.3

383

17.2

82.8

260

21.5

78.5

481

12.3

87.7

151

41.7

49.7

 

Ciprofloxacin

1,846

5.3

92.5

221

10.9

85.5

234

10.3

77.4

591

6.9

73.9

66

21.2

39.4

 

Gentamicin (HL Testing)

2,512

57.5

42.5

291

59.5

40.5

223

67.7

32.3

349

60.2

39.8

263

65.4

12.2

 

Teicoplanin

23

8.7

87.0

<10

NA

NA

234

86.3

13.7

517

97.9

2.1

266

99.6

0.4

Vancomycin

4,066

23.2

76.3

415

85.1

14.5

264

75.4

24.2

628

93.9

4.8

247

98.4

0.8

 
  1. aNCCLS breakpoints were used for all countries, except (CA-SFM) bNot tested cNot applicable if <10 isolates were tested